Monitoring Agency Report for the quarter ended 30th September, 2025
SMSPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
SMS Pharmaceuticals Limited has submitted its Monitoring Agency Report to NSE for the quarter ended 30th September 2025. This is a routine SEBI-mandated compliance filing required when a company has raised capital through instruments like QIP, rights issue, or preferential allotment. The monitoring agency, appointed by SEBI, tracks whether the company is using the funds raised for the purpose disclosed to investors. No details on deviations or specific fund usage are highlighted in the headline.
This is a standard regulatory filing and is typically neutral for the stock. Investors should check the full report for any flagged deviations from the stated purpose of the fund raise, which could be a concern.